- E28.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E28.2 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E28.2 – other international versions of ICD-10 E28.2 may differ.
ICD-10-CM E28.2 is grouped within Diagnostic Related Group(s):
- 742 Uterine and adnexa procedures for non-malignancy with cc/mcc
- 743 Uterine and adnexa procedures for non-malignancy without cc/mcc
- 760 Menstrual and other female reproductive system disorders with cc/mcc
- 761 Menstrual and other female reproductive system disorders without cc/mcc
Applicable To
- Sclerocystic ovary syndrome
- Stein-Leventhal syndrome
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Diagnosis Index entries containing back-references to E28.2:
- polycystic > ovary (noninflammatory) N83.9
- ovary, ovaries > polycystic Q61.3
- Stein-Leventhal syndrome > associated with N97.0
- Stein-Leventhal syndrome > due to N88.3
- ovary, ovaries > Polycystic (disease)
- bilateral polycystic ovarian > Syndrome
- ovary > Syndrome
- polycystic > ovary E28.2
- sclerocystic > ovary E28.2
- sclerocystic ovary > Syndrome
- Stein-Leventhal > Syndrome
- Stein\’s > Syndrome
- isosexual > Virilization (female) (suprarenal) E25.9